Vistagen Therapeutics, Inc. (VTGN)
0.6005
-0.01
(-2.25%)
USD |
NASDAQ |
Mar 06, 16:00
0.62
+0.02
(+3.25%)
After-Hours: 20:00
Vistagen Therapeutics Free Cash Flow : -60.67M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alector, Inc. | -184.07M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.63M |
| Cash from Investing (Quarterly) | 0.104M |
| Cash from Financing (Quarterly) | 2.112M |
| Free Cash Flow Per Share (Quarterly) | -0.4181 |
| Free Cash Flow to Equity (Quarterly) | -17.22M |
| Free Cash Flow to Firm (Quarterly) | -17.66M |
| Free Cash Flow Yield | -287.4% |